Royale Biotech Group Limited v Hi Globe International Trading Limited

Case [2021] NZHC 2441


IN THE HIGH COURT OF NEW ZEALAND AUCKLAND REGISTRY

I TE KŌTI MATUA O AOTEAROA TĀMAKI MAKAURAU ROHE

CIV-2020-404-1080

[2021] NZHC 2441

UNDER the Copyright Act 1994

BETWEEN

ROYALE BIOTECH GROUP LIMITED

Plaintiff

AND

HI GLOBE INTERNATIONAL TRADING LIMITED

Defendant

Hearing: On the papers

Counsel:

No appearance for the plaintiff JRE Wach for the defendant

Judgment:

17 September 2021


JUDGMENT OF JAGOSE J

[Costs]


This judgment was delivered by me on 17 September 2021 at 10.00am.

Pursuant to Rule 11.5 of the High Court Rules.

………………………… Registrar/Deputy Registrar

Solicitors:
James & Wells Solicitors – Auckland Branch

ROYALE BIOTECH GROUP LTD v HI GLOBE INTERNATIONAL TRADING LTD - Costs [2021] NZHC

2441 [17 September 2021]

[1]    My 23 August 2021 judgment, striking out Royale Biotech’s claims as an abuse of process and declaring its proceeding abandoned, awarded costs to Hi Globe and reserved their quantification.1

[2]    Hi Globe now seeks costs in the amount of $59,167.74, comprising 2B scale costs of $21,988.00 to the end of May 2021, during which Royale Biotech last took any step in this proceeding, and indemnity costs in the amount of $35,549.74 (including GST) thereafter (plus $1,620 disbursements). Royale Biotech makes no response.

[3]    Given my finding Royale Biotech’s abuse of process was to “use [this] proceeding effectively to prevent release of the bottles to Hi Globe”,2 its conduct meets the statutory threshold for indemnity costs.3 It was “distinctly bad behaviour”,4 constituting the “flagrant” or “very unreasonable” misconduct threshold for consideration of indemnity costs.5 Assuming Hi Globe to be GST-registered, GST is not recoverable.6

[4]I therefore order Royale Biotech pay Hi Globe costs in the amount of

$54,309.50 (comprised by 2B scale costs of $21,988.00 and indemnity costs in the amount of $30,912.80 (plus $1,408.70 disbursements)).

—Jagose J


1      Royale Biotech Group Ltd v Hi Globe International Trading Ltd [2021] NZHC 2176 at [13]–[14].

2 At [8].

3      High Court Rules 2016, r 14.6(4).

4      Bradbury v Westpac Banking Corporation [2009] 3 NZLR 400 (CA) at [26].

5      Prebble v Huata (No 2) [2005] NZSC 18, [2005] 2 NZLR 467 at [6]; and Flujo Holdings Pty Ltd v Merisant Co Inc [2018] NZCA 226 at [34].

6      New Zealand Venue and Event Management Ltd v Worldwide NZ LLC [2016] NZCA 282, (2016) 27 NZTC 22-058 at [17]. See also High Court Fees Regulations 2013, reg 24.

Details
AGLC
Royale Biotech Group Limited v Hi Globe International Trading Limited [2021] NZHC 2441
Case
[2021] NZHC 2441
Decision Date

CaseChat Overview and Summary

The case Royale Biotech Group Limited v Hi Globe International Trading Limited, decided in the High Court of New Zealand in Auckland, concerns a claim by Royale Biotech against Hi Globe, which was struck out as an abuse of process. The dispute involves allegations of copyright infringement regarding the release of bottles. The court awarded costs to Hi Globe and reserved the quantification for later determination.

The central legal issue was the assessment of costs incurred by Hi Globe, which sought $59,167.74. This amount included both 2B scale costs up until May 2021 and indemnity costs thereafter. Royale Biotech did not respond to Hi Globe's claim for costs. The court had to determine whether the costs claimed by Hi Globe were justified, particularly in light of the finding that Royale Biotech's actions constituted an abuse of process. The court concluded that Hi Globe's conduct met the statutory threshold for indemnity costs, as it was distinctly bad behaviour and constituted the "flagrant" or "very unreasonable" misconduct required for such costs.

The court found that Royale Biotech's abuse of process was intended to prevent the release of the bottles to Hi Globe. This finding supported the imposition of indemnity costs, which are awarded for conduct that is notably worse than mere negligence. The court ordered Royale Biotech to pay Hi Globe $54,309.50, which included both 2B scale and indemnity costs, minus the amount of GST, as it was not recoverable. This decision reflects the court's view that the misconduct by Royale Biotech was severe enough to warrant indemnity costs.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.